Latest News and Press Releases
Want to stay updated on the latest news?
-
PRESS RELEASE Mithra to initiate pk study FOR ESTELLE® First step toward bringing Estelle® to the Japanese...
-
Mithra reports 2016 annual results Significant operational progress across our transformational E4 (Estetrol) programs and our complex therapeutic solutions positions Mithra for long-term...
-
PRESS RELEASE Mithra Signs a Binding Term Sheet with the Japanese Leader in Women's Health Fuji Pharma to Commercialize Donesta® in Japan and ASEAN[1] Mithra signs a binding...
-
PRESS RELEASE Mithra agrees Exclusive LONG-TERM license and supply agreement with Mayne Pharma to commercialize Myring(TM) in the US Mithra grants its first exclusive license...
-
PRESS RELEASE Mithra agrees Exclusive LONG-TERM license and supply agreement with Mayne Pharma to commercialize Myring(TM) in the US Mithra grants its first exclusive license...
-
PRESS RELEASE MITHRA granted eur 1.9 million in non-dilutive funding Non-dilutive funding granted by the Walloon region Funding to support Estetrol (E4) and complex therapeutics solutions...
-
PRESS RELEASE MITHRA COMPLETES RECRUITMENT FOR European phase iii estelle® study Liège, Belgium, 07 February 2017 - Mithra Pharmaceuticals (Euronext Brussels: MITRA), a company focused on...
-
PRESS RELEASE Mithra Strengthens Position in the Belgian Contraception Market Mithra builds on leading position in Belgian contraceptive market Mithra achieves significant increase in 2016...
-
PRESS RELEASE Mithra plans to submit myring for us and eu approval in q2 2017 Planned submissions follow successful trials demonstrating bioequivalence to NuvaRing® Liège, Belgium, 24...
-
PRESS RELEASE MITHRA ANNOUNCES US PATENT ALLOWANCE FOR THE USE OF ESTETROL AS EMERGENCY CONTRACEPTIVE Liège, Belgium, 18 January 2017 - Mithra Pharmaceuticals (Euronext Brussels: MITRA), a...